Immunomodulation via lentiviral delivery from microporous scaffolds alters metastatic tumor cell recruitment in vivo

Keyphrases

• Immunomodulation 100%
• Immune Cells 100%
• Metastatic Cells 100%
• Cell Recruitment 100%
• Lentiviral Delivery 100%
• Microporous Scaffolds 100%
• Tumor Cells 50%
• Xenogeneic 50%
• Breast Cancer Susceptibility Gene 1 (BRCA1) 50%
• Relative Contribution 50%
• Biomedical Implants 50%
• Clinical Treatment 50%
• Pre-metastatic Niche 50%
• Shea 50%
• Curative Intent 50%
• Clinical Methods 50%
• Organ Function 50%
• Cell-Associated 50%
• Palliative Care 50%
• Cancer Types 50%
• Distant Metastasis 50%
• Syngeneic Mouse Model 50%
• Mouse Breast Cancer 50%
• Metastatic Dissemination 50%
• Statement of Purpose 50%
• Metastatic Colonization 50%

Medicine and Dentistry

• Tumor Cell 100%
• Metastatic Carcinoma 100%
• Immunomodulation 100%
• Immunocompetent Cell 100%
• Malignant Neoplasm 50%
• Breast Cancer 50%
• Cancer Cell 50%
• Implant 50%
• Cytokine 50%
• Biocompatible Material 50%
• Distant Metastasis 50%
• Symptomatic Treatment 50%
• Clinical Method 50%